MR Solutions Now Offers the Widest Range of Preclinical Nuclear Medicine Imaging Systems of Any Manufacturer

A world leader in helium free MRI systems for preclinical research laboratories MR Solutions has now developed the largest and most advanced range of preclinical nuclear medicine combination systems of any manufacturer.

The PET and SPECT nuclear systems can be stand-alone or clipped onto the front of any of MR Solutions’ extensive range of high field, liquid helium free MRI systems or its range of cutting edge CT systems. The PET scanners can also be configured to operate as an insert in the bore of all the MRI systems providing simultaneous imaging. The PET and SPECT scanners range in size from 15 g for small rodents up to 12 kgs for larger animals.

The PET insert (for simultaneous scanning) or PET clip-on module (for sequential scanning) use the latest silicon photomultiplier (SiPM) technology. This provides true depth of interaction (DOI) from hardware with two pixelated layers of scintillator crystal with different matrices providing <0.8 mm resolution. All of the PET modules are fitted with MR Solution’s superior ringless detector technology.

The SPECT clip-on modules are available in different configurations with a range of transaxial views allowing optimal imaging for different sized animals.

All of MR Solution’s preclinical scanning systems are fitted with the easy to use Preclinical Scan multimodality interface. This software provides access to all the functions – MRI/CT/PET/SPECT.  Advanced functionalities are available for experienced users.

Both the CT and MRI scanners include a motorized animal bed allowing the animal to be scanned without any manual input from the operator. These precision animal beds are compatible across all of MR Solutions’ CT and MRI ranges.

MR Solutions, based in the UK, has over 30 years’ experience and in excess of 2000 installations including spectrometer sales across the world. MR Solutions holds the prestigious Queen’s Award for Enterprise awards, achieving this for Innovation in 2016 and 2019 and for International Trade in 2017. MR Solutions also has offices in the US and technical support in all the major centers.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version